• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On July 8th, China Biopharmaceutical (01177.HK) announced a further deepening of its strategic cooperation with GlaxoSmithKline (GSK.N). Under the expanded cooperation agreement, Chia Tai Tianqing Pharmaceutical Group, a subsidiary of China Biopharmaceutical, will be fully responsible for the import, distribution, hospital access, and promotion of two innovative respiratory drugs in mainland China: Flutemetixyl Inhalation Powder (Tronex) and Umemetidine-Vilanterol Inhalation Powder (Olex). Previously, the two companies had already reached a cooperation agreement on the localization of innovative drugs in the field of liver disease.Bernstein: Lowered its price target for Netflix (NFLX.O) from $110 to $100.Citigroup raised its price target for Johnson & Johnson (JNJ.N) from $285 to $298.Broadcom (AVGO.O) recovered some of its losses in pre-market trading and is currently down 0.5%. The company has reached an agreement with Apple (AAPL.O) to produce more than 15 billion chips.On July 8, Xi Jinping attended the National Science and Technology Awards Conference, the General Assembly of the Chinese Academy of Sciences and the Chinese Academy of Engineering, and the 11th National Congress of the China Association for Science and Technology, and delivered an important speech. Xi Jinping emphasized the need to promote the deep integration of scientific and technological innovation and industrial innovation, and to open up channels for the accelerated transformation of science and technology into real productive forces. Scientific and technological innovation should be application-oriented, while industrial innovation should focus on raising scientific questions. He stressed strengthening the national technology transfer system, creating diversified application scenarios and high-level industrial clusters, and promoting the application and iterative upgrading of independently developed technologies and products. He also called for improving the intellectual property protection system and building a science and technology finance system adapted to scientific and technological innovation.

As investors forecast Eurozone GDP, the EUR/GBP exchange rate fluctuates around 0.8370

Daniel Rogers

Jul 29, 2022 10:59

 截屏2022-07-29 上午9.51.38.png

 

The EUR/GBP pair is fluctuating in a narrow range between 0.8366 and 0.8380 in the early Tokyo session. The asset saw a robust buying response on Friday after hitting a fresh three-month low of 0.8346 on Thursday. A buying response often indicates that traders perceived the asset as a value bet and built up sizeable long holdings. On the downside, the cross is displaying indications of fatigue, and a rebound is anticipated close to the round-number resistance level of 0.8400.

 

During today's session, investors will pay close attention to data on the Gross Domestic Product (GDP) of the Eurozone. The market believes that annual economic estimates may drop from 5.4 percent to 3.4 percent. While the quarterly GDP will drop from 0.6 percent in the prior report to 0.2 percent. The shared currency's bullish indication can be destroyed by a repetition of the same event.

 

Consumer attitudes are negatively impacted by growing fears of an energy catastrophe in the eurozone. Natural gas consumption will undoubtedly rise as Winter draws near, which is marked by a rise in energy demand. The eurozone administration is looking for candidates who can fulfill the region's high energy demand, but the search will take some time.

 

Investor focus will shift to the Bank of England's interest rate announcement on the British front (BOE). Interest rates are anticipated to climb further under Governor Andrew Bailey of the Bank of England given that the inflation rate has reached 9.4% and doesn't appear to be nearing its peak. Pricing pressures in the UK are constantly increasing and may soon hit double digits.